Consequently, the current study has been designed to investigate the differences in the memory T cell response among SARS-CoV-2 infected patients compared to healthy controls through assessing the proportions of several subsets of CD4+ and CD8+ memory T cells, taking into consideration different comorbidities affecting COVID-19 patients. This evidence concerns the gene CD4 and COVID-19.